Flammer Martina M.D. sold $3.5M of INSM
Flammer Martina M.D. (Chief Medical Officer) sold 27,173 shares of INSMED Inc (INSM) at an average of $128.61 ($127.00–$129.40, $3.49M total) across 2 trades on 2026-08-06 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed event is a pre-arranged open-market sale of INSM shares totaling about $3.49M, with holdings after the transaction of 60,486 shares.
Market read
Traders may treat this as routine insider activity unless paired with other negative company-specific developments.
What to watch
The article does not state whether the CMO’s sale was part of a larger multi-tranche program, nor does it provide post-sale performance context or any concurrent company news.
Background
This is an SEC Form 4 insider transaction disclosure for INSMED Inc, reported by its Chief Medical Officer.
Ticker impact
INSMED CMO Flammer Martina sold about $3.49M of INSM shares in open-market trades under a 10b5-1 plan, per Form 4.
Low near-term impact; any reaction is likely limited to short-lived sentiment noise rather than a durable repricing.
The filing is a disclosed open-market sale with a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.
Market effects
Minimal; insider selling in a single biotech name does not, by itself, reset sector risk appetite.
None indicated.
None indicated.
Counterpoint
Even with a 10b5-1 plan, repeated insider sales can still coincide with internal caution about near-term catalysts, so traders may watch for follow-on disclosures.
Key entities
- issuerINSMED Inc
US-listed company whose insider transaction is disclosed on Form 4.
- insiderFlammer Martina M.D.
Chief Medical Officer who executed the reported open-market sales under a 10b5-1 plan.
